nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—Phenindamine—HRH1—atherosclerosis	0.0156	0.158	CrCbGaD
Metixene—Methdilazine—HRH1—atherosclerosis	0.0105	0.107	CrCbGaD
Metixene—Diphenylpyraline—HRH1—atherosclerosis	0.00853	0.0862	CrCbGaD
Metixene—Alimemazine—HRH1—atherosclerosis	0.00769	0.0777	CrCbGaD
Metixene—Cyclizine—HRH1—atherosclerosis	0.00686	0.0694	CrCbGaD
Metixene—Mequitazine—HRH1—atherosclerosis	0.00662	0.0669	CrCbGaD
Metixene—Maprotiline—HRH1—atherosclerosis	0.00606	0.0612	CrCbGaD
Metixene—Mirtazapine—HRH1—atherosclerosis	0.00554	0.056	CrCbGaD
Metixene—Cyproheptadine—HRH1—atherosclerosis	0.00537	0.0543	CrCbGaD
Metixene—Mesoridazine—HRH1—atherosclerosis	0.00465	0.047	CrCbGaD
Metixene—Prochlorperazine—HRH1—atherosclerosis	0.0045	0.0455	CrCbGaD
Metixene—Mianserin—HRH1—atherosclerosis	0.00407	0.0411	CrCbGaD
Metixene—Thioridazine—HRH1—atherosclerosis	0.00351	0.0354	CrCbGaD
Metixene—Promethazine—HRH1—atherosclerosis	0.0033	0.0333	CrCbGaD
Metixene—Quetiapine—HRH1—atherosclerosis	0.00316	0.0319	CrCbGaD
Metixene—Promazine—HRH1—atherosclerosis	0.0029	0.0293	CrCbGaD
Metixene—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	0.000208	0.000231	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000208	0.000231	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000207	0.00023	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000205	0.000228	CbGpPWpGaD
Metixene—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000202	0.000225	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	0.000202	0.000224	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	0.000202	0.000224	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000199	0.000221	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000198	0.00022	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGT—atherosclerosis	0.000197	0.000219	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000196	0.000218	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MMP3—atherosclerosis	0.000195	0.000216	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF2—atherosclerosis	0.000194	0.000215	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOB—atherosclerosis	0.000194	0.000215	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	0.000193	0.000214	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—LEP—atherosclerosis	0.000193	0.000214	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—APOE—atherosclerosis	0.000193	0.000214	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CAV1—atherosclerosis	0.000191	0.000212	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—APOA1—atherosclerosis	0.000191	0.000212	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.00019	0.000211	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000189	0.00021	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000189	0.000209	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGT—atherosclerosis	0.000189	0.000209	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000189	0.000209	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOB—atherosclerosis	0.000188	0.000209	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000188	0.000209	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000187	0.000208	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	0.000187	0.000207	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000186	0.000207	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EDN1—atherosclerosis	0.000185	0.000206	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000185	0.000206	CbGpPWpGaD
Metixene—CHRM3—Metabolism—LPL—atherosclerosis	0.000185	0.000205	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—LEP—atherosclerosis	0.000185	0.000205	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—APOE—atherosclerosis	0.000185	0.000205	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000185	0.000205	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ESR1—atherosclerosis	0.000184	0.000205	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.000184	0.000204	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL5—atherosclerosis	0.000184	0.000204	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.000183	0.000204	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CAV1—atherosclerosis	0.000183	0.000203	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000183	0.000203	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—APOA1—atherosclerosis	0.000183	0.000203	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—F2—atherosclerosis	0.000182	0.000202	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000182	0.000202	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GPX1—atherosclerosis	0.000181	0.0002	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—LPL—atherosclerosis	0.00018	0.0002	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ESR1—atherosclerosis	0.000176	0.000196	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CD36—atherosclerosis	0.000176	0.000195	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	0.000175	0.000194	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—F2—atherosclerosis	0.000174	0.000193	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000174	0.000193	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	0.000174	0.000193	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000174	0.000193	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000172	0.000191	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SPP1—atherosclerosis	0.00017	0.000189	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	0.00017	0.000188	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000168	0.000187	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000168	0.000186	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000168	0.000186	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000167	0.000185	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	0.000167	0.000185	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	0.000167	0.000185	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000167	0.000185	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000166	0.000184	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000165	0.000184	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—INS—atherosclerosis	0.000165	0.000183	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPARA—atherosclerosis	0.000164	0.000181	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000163	0.00018	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL2—atherosclerosis	0.000162	0.00018	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000162	0.00018	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000161	0.000179	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000161	0.000178	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000161	0.000178	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.00016	0.000178	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	0.00016	0.000177	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.00016	0.000177	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF1—atherosclerosis	0.00016	0.000177	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000159	0.000177	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000159	0.000176	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGT—atherosclerosis	0.000158	0.000176	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000158	0.000176	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000158	0.000175	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—INS—atherosclerosis	0.000158	0.000175	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	0.000158	0.000175	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000157	0.000174	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL2—atherosclerosis	0.000155	0.000172	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000155	0.000172	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOE—atherosclerosis	0.000155	0.000172	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000155	0.000172	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGT—atherosclerosis	0.000154	0.000171	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CAV1—atherosclerosis	0.000154	0.000171	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOA1—atherosclerosis	0.000153	0.00017	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000153	0.00017	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF1—atherosclerosis	0.000153	0.00017	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	0.000151	0.000168	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000151	0.000168	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—LEP—atherosclerosis	0.000151	0.000167	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOE—atherosclerosis	0.000151	0.000167	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.00015	0.000167	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CAV1—atherosclerosis	0.000149	0.000166	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000149	0.000165	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOA1—atherosclerosis	0.000149	0.000165	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000147	0.000163	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000147	0.000163	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000146	0.000162	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000146	0.000162	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000145	0.000161	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	0.000145	0.000161	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NOS3—atherosclerosis	0.000145	0.00016	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000145	0.00016	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ESR1—atherosclerosis	0.000144	0.00016	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—F2—atherosclerosis	0.000142	0.000158	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.00014	0.000155	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NOS3—atherosclerosis	0.000138	0.000154	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	0.000136	0.000151	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	0.000136	0.000151	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	0.000136	0.000151	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPARG—atherosclerosis	0.000135	0.00015	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	0.000134	0.000149	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGT—atherosclerosis	0.000133	0.000147	CbGpPWpGaD
Metixene—CHRM3—Metabolism—INS—atherosclerosis	0.000133	0.000147	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGT—atherosclerosis	0.000132	0.000147	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGT—atherosclerosis	0.000131	0.000146	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	0.00013	0.000145	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOE—atherosclerosis	0.00013	0.000144	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—LEP—atherosclerosis	0.00013	0.000144	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOE—atherosclerosis	0.00013	0.000144	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—LEP—atherosclerosis	0.00013	0.000144	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CAV1—atherosclerosis	0.000129	0.000143	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—INS—atherosclerosis	0.000129	0.000143	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOA1—atherosclerosis	0.000129	0.000143	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CAV1—atherosclerosis	0.000129	0.000143	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOE—atherosclerosis	0.000128	0.000143	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—LEP—atherosclerosis	0.000128	0.000143	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	0.000128	0.000142	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOA1—atherosclerosis	0.000128	0.000142	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CAV1—atherosclerosis	0.000127	0.000141	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOA1—atherosclerosis	0.000127	0.000141	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL2—atherosclerosis	0.000127	0.000141	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF1—atherosclerosis	0.000125	0.000138	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ESR1—atherosclerosis	0.000124	0.000138	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	0.000124	0.000138	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ESR1—atherosclerosis	0.000124	0.000137	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	0.000123	0.000136	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—F2—atherosclerosis	0.000123	0.000136	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ESR1—atherosclerosis	0.000123	0.000136	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—F2—atherosclerosis	0.000122	0.000136	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—IL6—atherosclerosis	0.000122	0.000135	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ALB—atherosclerosis	0.000122	0.000135	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—F2—atherosclerosis	0.000121	0.000134	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	0.000119	0.000132	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	0.000118	0.000131	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	0.000117	0.00013	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	0.000117	0.00013	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—IL6—atherosclerosis	0.000117	0.00013	CbGpPWpGaD
Metixene—CHRM3—Metabolism—NOS3—atherosclerosis	0.000116	0.000129	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MMP9—atherosclerosis	0.000116	0.000129	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	0.000116	0.000129	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	0.000115	0.000127	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NOS3—atherosclerosis	0.000113	0.000125	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	0.000113	0.000125	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	0.000113	0.000125	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	0.000112	0.000125	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	0.000112	0.000124	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—INS—atherosclerosis	0.000111	0.000123	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MMP9—atherosclerosis	0.000111	0.000123	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	0.000111	0.000123	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—INS—atherosclerosis	0.000111	0.000123	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	0.00011	0.000122	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—INS—atherosclerosis	0.00011	0.000122	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL2—atherosclerosis	0.000109	0.000121	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL2—atherosclerosis	0.000109	0.000121	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	0.000108	0.00012	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL2—atherosclerosis	0.000108	0.00012	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	0.000108	0.00012	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF1—atherosclerosis	0.000108	0.000119	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF1—atherosclerosis	0.000107	0.000119	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PTGS2—atherosclerosis	0.000106	0.000118	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF1—atherosclerosis	0.000106	0.000118	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	0.000104	0.000116	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—STAT3—atherosclerosis	0.000103	0.000114	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	0.000102	0.000113	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	0.000102	0.000113	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	0.000101	0.000112	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	0.0001	0.000111	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	9.98e-05	0.000111	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—STAT3—atherosclerosis	9.88e-05	0.00011	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	9.86e-05	0.000109	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NOS3—atherosclerosis	9.75e-05	0.000108	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NOS3—atherosclerosis	9.72e-05	0.000108	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	9.67e-05	0.000107	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NOS3—atherosclerosis	9.63e-05	0.000107	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	9.56e-05	0.000106	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—IL6—atherosclerosis	9.52e-05	0.000106	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	9.44e-05	0.000105	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	9.16e-05	0.000102	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MMP9—atherosclerosis	9.06e-05	0.000101	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	8.96e-05	9.95e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	8.81e-05	9.78e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	8.78e-05	9.75e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	8.65e-05	9.6e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	8.62e-05	9.57e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	8.54e-05	9.48e-05	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	8.36e-05	9.27e-05	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	8.33e-05	9.24e-05	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	8.25e-05	9.15e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL6—atherosclerosis	8.22e-05	9.13e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL6—atherosclerosis	8.2e-05	9.1e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	8.13e-05	9.03e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL6—atherosclerosis	8.12e-05	9.01e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—STAT3—atherosclerosis	8.05e-05	8.94e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP9—atherosclerosis	7.82e-05	8.68e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP9—atherosclerosis	7.8e-05	8.65e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	7.74e-05	8.59e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP9—atherosclerosis	7.72e-05	8.57e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	7.72e-05	8.56e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	7.69e-05	8.54e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	7.64e-05	8.48e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	7.61e-05	8.44e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	7.59e-05	8.42e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	7.58e-05	8.42e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	7.56e-05	8.39e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	7.51e-05	8.34e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	7.49e-05	8.31e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	7.46e-05	8.28e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL6—atherosclerosis	7.21e-05	8e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	7.02e-05	7.8e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	7e-05	7.77e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—STAT3—atherosclerosis	6.96e-05	7.72e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	6.93e-05	7.7e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—STAT3—atherosclerosis	6.93e-05	7.69e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL6—atherosclerosis	6.9e-05	7.66e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—STAT3—atherosclerosis	6.87e-05	7.62e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AKT1—atherosclerosis	6.65e-05	7.38e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	6.65e-05	7.37e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	6.62e-05	7.35e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	6.56e-05	7.28e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	6.45e-05	7.16e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	6.43e-05	7.13e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AKT1—atherosclerosis	6.37e-05	7.06e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	6.36e-05	7.06e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL6—atherosclerosis	5.63e-05	6.24e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AKT1—atherosclerosis	5.34e-05	5.93e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AKT1—atherosclerosis	5.19e-05	5.76e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL6—atherosclerosis	4.86e-05	5.39e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL6—atherosclerosis	4.84e-05	5.37e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL6—atherosclerosis	4.8e-05	5.32e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AKT1—atherosclerosis	4.48e-05	4.97e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AKT1—atherosclerosis	4.47e-05	4.96e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AKT1—atherosclerosis	4.42e-05	4.91e-05	CbGpPWpGaD
